...
LLYMEGA

Eli Lilly and Company

HealthcareDrug Manufacturers - General
$1,052.20
$0.31(+2.95%)
52W$623.78
$1133.95
FinancialsValuationvs JNJ
Updated Mar 1, 12:00 AM
RSI47
RS Rating76/99
Beta0.65
Volatility43%
F-Score6/9
Mkt Cap$941.7B
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Eli Lilly and Company shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 76), indicating performance broadly in line with the market. Earnings growth of 480% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
76
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
0.65
vs S&P 500
DEFENSIVE
52W Position
84%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1,053.85
50 SMA > 100 SMA$998.54
100 SMA > 150 SMA$911.36
150 SMA > 200 SMA$876.18

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1037.73+1.39%ABOVE
50 SMA$1053.85-0.16%BELOW
100 SMA$998.54+5.37%ABOVE
150 SMA$911.36+15.45%ABOVE
200 SMA$876.18+20.09%ABOVE

Price Performance

1D+3.0%
1W-0.6%
1M+2.8%
3M-2.2%
6M+43.8%
YTD-2.6%
1Y+14.3%
3Y+50.1%
52-Week Trading Range84% from low
$1052.20
52W Low$623.78
52W High$1133.95

Technical Indicators

RSI (14)NEUTRAL
46.9
305070
VCP ScoreWARM
6/10
Base depth: 14.9%

Risk Profile

Beta
0.65
52W Vol
43%
ATR
$34.85
Max DD (1Y)
-33%

Volume Analysis

Today
1.1K
50D Avg
2.58M
Vol Ratio
0.00x
Liquidity
VERY LIQUID

Earnings Momentum

Q4'24+102%
$4.88
Q1'25+23%
$3.06
Q2'25+92%
$6.29
Q3'25+480%
$6.21
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+8.67%
5 Years:+15.08%
3 Years:+16.73%
TTM:+45.41%

Compounded Profit Growth

10 Years:+18.47%
5 Years:+6.15%
3 Years:+26.03%
TTM:+120.97%

Stock Price CAGR

10 Years:+30.76%
5 Years:+38.50%
3 Years:+50.09%
1 Year:+14.29%

Return on Equity

10Y Avg:60.0%
5Y Avg:83.0%
3Y Avg:65.1%
Last Year:77.2%

Key Metrics

Market Cap$941.7B
Gross Margin81.3%
Net Margin23.5%
Piotroski F-Score6/9

More LLY Analysis

Full Financial AnalysisDCF & Intrinsic ValueTotal Return Calculator

Compare With

LLY vs JNJJNJAZNBMYCELG-RI

Data Dictionary

RS Rating (Relative Strength)

Measures 12-month price performance vs all stocks. Rating of 76 meansLLY outperformed 76% of all stocks. Scores >80 indicate market leaders.

Beta

Measures volatility vs S&P 500. Beta of 0.65 means 35% less volatile than market.

Piotroski F-Score

9-point financial strength score based on profitability, leverage, and efficiency. Score of 6/9. Scores 7-9 = strong, 4-6 average, 0-3 = weak.

VCP (Volatility Contraction Pattern)

Measures base formation quality. Higher scores indicate tighter consolidation near pivot points. Score of 6/10 with WARM status.

Frequently Asked Questions

Is LLY in an uptrend right now?

LLY has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is LLY overbought or oversold?

LLY's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.

Is LLY outperforming the market?

LLY has a Relative Strength (RS) Rating of 76 out of 99. LLY is performing about average compared to the market.

Where is LLY in its 52-week range?

LLY is trading at $1052.20, which is 93% of its 52-week high ($1133.95) and 84% above its 52-week low ($623.78).

How volatile is LLY?

LLY has a Beta of 0.65 and 52-week volatility of 43%. It's less volatile than the S&P 500 - generally more stable.